Afrikaans Albanian Amharic Arabic Armenian Azerbaijani Basque Belarusian Bengali Bosnian Bulgarian Catalan Cebuano Chichewa Chinese (Simplified) Chinese (Traditional) Corsican Croatian Czech Danish Dutch English Esperanto Estonian Filipino Finnish French Frisian Georgian German Greek Gujarati Haitian Creole Hausa Hawaiian Hebrew Hindi Hmong Hungarian Icelandic Igbo Indonesian Irish Italian Japanese Javanese Kannada Kazakh Khmer Korean Kurdish (Kurmanji) Lao Latin Latvian Lithuanian Luxembourgish Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Myanmar (Burmese) Nepali Norwegian Pashto Persian Polish Portuguese Punjabi Romanian Russian Samoan Serbian Sesotho Sindhi Sinhala Slovak Slovenian Somali Spanish Sudanese Swahili Swedish Tamil Telugu Thai Turkish Ukrainian Urdu Uzbek Vietnamese Xhosa
The last two decades saw an increase in the administration of parenteral drugs by pre-filled syringes. Use of pre-filled syringe increases with the technological development in devices used for administering sophisticated drugs.
Self–filling syringe is not only a slow process but also has the chance of incorrect dosing and spillage. The key benefits of Pre-filled syringes (specialized delivery technology) are:
Aristopharma has set up a global standard pre-filled syringe filling facility in its sterile manufacturing zone. The facility is planned and designed with fine tuned future orientation to meet the local as well as international demand.
All latest model machineries of renowned sources have been employed in this set up. The whole process is carried out in aseptic environment and under strict procedures recommended in cGMP guidelines.
Presently Aristopharma is producing enoxaparin pre-filled syringe and some biotech products like Filgrastim, Peginterferon, Fondaparinux etc. are in pipeline which would be manufactured soon.